Live News EQUITY FLASH L impact Nov 12, 2026, 09:18 PM UTC ProKidney Q3 loss widens on higher R&D costs ProKidney Q3 loss widens on higher R&D costs Overview U.S. cell therapy firm's Q3 net loss widened a PROK SquawkNews Desk